Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy

Cancer immunotherapy is an attractive treatment option under clinical settings. However, the major challenges of immunotherapy include limited patient response, limited tumor specificity, immune-related adverse events, and immunosuppressive tumor microenvironment. Therefore, nanoparticle (NP)-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Seungho, Park, Jooho, Shim, Man Kyu, Um, Wooram, Yoon, Hong Yeol, Ryu, Ju Hee, Lim, Dong-Kwon, Kim, Kwangmeyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831456/
https://www.ncbi.nlm.nih.gov/pubmed/31695807
http://dx.doi.org/10.7150/thno.38425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831456/
https://www.ncbi.nlm.nih.gov/pubmed/31695807
http://dx.doi.org/10.7150/thno.38425

Ejemplares similares